Recent Finacing
Recent Raise
Ambros Therapeutics is a clinical-stage biotech developing neridronate to treat Complex Regional Pain Syndrome Type 1 (CRPS-1).
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at Ambros Therapeutics.
